pro-platelet basic protein ; Homo sapiens






407 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 66177 Short and long term effects of radioiodine and antithyroid drugs on T4 binding proteins, free T4 and T3, during Graves' disease therapy. Horm Metab Res 1977 Jan 1
2 77677 Complete covalent structure of human beta-thromboglobulin. Biochemistry 1978 May 2 1
3 94458 Beta thromboglobulin and glycosylated haemoglobin in diabetes mellitus. Scand J Haematol 1979 Nov 1
4 102876 Effects of prostaglandin E1 on platelet loss during in vivo and in vitro extracorporeal circulation with a bubble oxygenator. J Thorac Cardiovasc Surg 1979 Jan 1
5 162473 Direct animal and indirect human evidence of altered platelet function in diabetics. Metabolism 1979 Apr 3
6 420716 Connective tissue activation. XIV. Composition and actions of a human platelet autacoid mediator. Arthritis Rheum 1979 Mar 10
7 641404 Connective tissue activation. XIII. Stimulation of sulfated glycosaminoglycan synthesis in human connective tissue cells by peptide mediators from lymphocytes and platelets. J Lab Clin Med 1978 May 5
8 1287314 [Alterations in the functional activity of platelets in patients with angina pectoris during the cold test]. Kardiologiia 1992 Sep 1
9 1310599 Mastoparan promotes exocytosis and increases intracellular cyclic AMP in human platelets. Evidence for the existence of a Ge-like mechanism of secretion. Biochem J 1992 Jan 15 1
10 1315576 Activation of phospholipase A2 and beta-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. Biochim Biophys Acta 1992 Mar 25 7
11 1315646 Alpha-adrenoceptor blockade by phentolamine inhibits adrenaline-induced platelet activation in vivo without affecting resting measurements. Clin Sci (Lond) 1992 Apr 1
12 1323612 Recombinant tumor necrosis factor-alpha potentiates neutrophil degranulation in response to host defense cytokines neutrophil-activating peptide 2 and IL-8 by modulating intracellular cyclic AMP levels. J Immunol 1992 Aug 15 5
13 1337630 Significance of platelet beta-adrenoceptors for platelet responses in vivo and in vitro. Thromb Haemost 1992 Dec 7 1
14 1349904 The effect of antihypertensive drugs on in vivo platelet activity in essential hypertension. J Hypertens 1992 Apr 1
15 1372016 Connective tissue-activating peptide-III and its derivative, neutrophil-activating peptide-2, release histamine from human basophils. J Allergy Clin Immunol 1992 Mar 8
16 1379080 Stabilization of standard platelet concentrates and minimization of the platelet storage lesion by a prostacyclin analogue. Ann Hematol 1992 Jun 2
17 1383321 Activation of human basophils through the IL-8 receptor. J Immunol 1992 Oct 15 2
18 1386051 Evidence for a storage pool defect in platelets from cirrhotic patients with defective aggregation. Gastroenterology 1992 Aug 1
19 1387933 Effects of adrenaline infusion on serum thromboxane B2 and plasma beta-thromboglobulin levels in hypertensive and normotensive subjects. Nouv Rev Fr Hematol 1992 1
20 1410527 Platelet activation and prostacyclin release in essential hypertension. Prostaglandins 1992 Sep 1
21 1436601 [Ticlopidine and platelet function]. Minerva Med 1992 Sep 1
22 1438244 High- and low-affinity binding of GRO alpha and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc Natl Acad Sci U S A 1992 Nov 1 2
23 1457589 Some storage characteristics of buffy coats used for preparation of platelet concentrates. Ann Hematol 1992 Dec 1
24 1527075 Regulation of glucose transporters by connective tissue activating peptide-III isoforms. J Biol Chem 1992 Sep 25 15
25 1531540 Isolation, characterization, and immunological detection of neutrophil-activating peptide 2: a proteolytic degradation product of platelet basic protein. Proc Soc Exp Biol Med 1992 Feb 1
26 1543805 Adsorption of coagulation proteins from whole blood on to polymer materials: relation to platelet activation. Biomaterials 1992 1
27 1546956 G-protein activation by interleukin 8 and related cytokines in human neutrophil plasma membranes. Biochem J 1992 Mar 1 4
28 1579804 Immunohistochemical and functional studies of glycoprotein 60 (gp60) in platelets. Rheumatol Int 1992 1
29 1601510 Hemostatic disturbances induced by two hollow-fiber hemodialysis membranes. Int J Artif Organs 1992 May 1
30 1615496 Ticlopidine and platelet function in healthy volunteers. Thromb Res 1992 Mar 1 1
31 1622417 Connective tissue activation. XXXV. Detection of connective tissue activating peptide-III isoforms in synovium from osteoarthritis and rheumatoid arthritis patients: patterns of interaction with other synovial cytokines in cell culture. Arthritis Rheum 1992 Jul 1
32 1692035 Relationship of one form of human histamine-releasing factor to connective tissue activating peptide-III. J Clin Invest 1990 May 1
33 1716285 IL-8 inhibits histamine release from human basophils induced by histamine-releasing factors, connective tissue activating peptide III, and IL-3. J Immunol 1991 Sep 15 3
34 1725542 Platelet function and fibrinolytic activity in hypertension: differential effects of calcium antagonists and beta-adrenergic receptor blockers. J Cardiovasc Pharmacol 1991 4
35 1743589 The effect of low affinity platelet factor 4 (LAPF4) secreted by human megakaryoblastic cell line (MEG-01) upon human bone marrow fibroblasts. Haematologica 1991 May-Jun 2
36 1766495 Evaluation of platelets and hemostasis during hemodialysis with six different membranes. Nephron 1991 4
37 1824807 Increased microvascular permeability in vivo in response to intradermal injection of neutrophil-activating protein (NAP-2) in rabbit skin. Am J Pathol 1991 Jan 1
38 1824823 Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. Cancer Res 1991 Jan 1 1
39 1826095 Hemodialysis and heparin. Alternative methods of measuring heparin and of detecting activation of coagulation. Clin Nephrol 1991 Jan 1
40 1832058 Plasma levels of plasminogen activator inhibitor type 1, beta-thromboglobulin, and fibrinopeptide A before, during, and after treatment of acute myocardial infarction with alteplase. Blood 1991 Sep 15 2
41 1833211 Polymorphonuclear leukocyte-dependent modulation of platelet function: effect of cloricromene. Eur J Pharmacol 1991 May 30 4
42 1833592 The influence of preoperative anticoagulation on heparin response during cardiopulmonary bypass. J Thorac Cardiovasc Surg 1991 Oct 1
43 1835913 Heparin-releasable platelet factor 4 in patients with coronary artery disease. Clin Cardiol 1991 Sep 4
44 1836140 Biosynthesis and secretion of beta-thromboglobulin by a human megakaryoblastic cell line (MEG-01). Int J Hematol 1991 Apr 7
45 1837769 [Evaluation of arteriolar reactivity and blood coagulation parameters during picotamide treatment]. Clin Ter 1991 Oct 15-31 1
46 1873479 Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III. Cytokine 1991 Jul 1
47 1966891 Factors affecting dense and alpha-granule secretion from electropermeabilized human platelets: Ca(2+)-independent actions of phorbol ester and GTP gamma S. Cell Regul 1990 Dec 4
48 2006757 Hemorheologic and coagulative pattern in hypercholesterolemic subjects treated with lipid-lowering drugs. Angiology 1991 Feb 1
49 2037605 Neutrophil-activating peptide 2 and gro/melanoma growth-stimulatory activity interact with neutrophil-activating peptide 1/interleukin 8 receptors on human neutrophils. J Biol Chem 1991 Jun 5 1
50 2039437 Formation of neutrophil-activating peptide 2 from platelet-derived connective-tissue-activating peptide III by different tissue proteinases. Biochem J 1991 May 1 2